A trial comparing ruxolitinib with best available treatment for polycythaemia vera (MITHRIDATE)

This trial is comparing ruxolitinib with the best available treatment for people with high risk polycythaemia vera.

You have high risk polycythaemia vera if you have, or have had, a high white blood cell count and at least 1 of the following. You:

• are over 60 years old

• have had a blood clot or bleeding problem

• have, or have had, a high count of blood cells called platelets